Infectious diseases were the second largest subset of publications in the CRISPR dataset extracted from the CAS Content Collection. A total of 25% of all journal publications and 22% of all patent publications mentioned infectious diseases. There has been a steep increase over the past few years in number of publications on infectious diseases and CRISPR technology especially marked for bacterial and viral infectious diseases (Figure ). A majority of these documents appear to focus on viral, followed by bacterial and lastly fungal studies.